ArticleSAGE open medicine2026
Uptake of human papillomavirus vaccine among school girls and its associated factors in Addis Ababa, Ethiopia.
Article in SAGE open medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To assess the HPV vaccine uptake among adolescent public high school girls aged 15-19 years and the factors associated with it in Addis Ababa, Ethiopia. Methods: A school-based cross-sectional study was conducted among 754 adolescent public high school girls aged 15-19 years in Addis Ababa. A multistage cluster sampling technique was used, and data were collected using a structured self-administered questionnaire. Data were analyzed using Stata version 14. We calculated the proportion (95% CI) to measure uptake. A multivariable logistic regression analysis was used to identify the factors associated with HPV vaccine uptake. Results: HPV vaccine uptake was reported by 55.3% (95% CI: 51.7%, 58.8%) of school girls aged 15-19 years. Knowing the HPV vaccine [AOR=3.0, (95% CI:2.2, 4.2), p-value 0.001] and a positive attitude toward the HPV vaccine [AOR=3.3, (95% CI:1.6, 6.9), p-value 0.001] were significantly associated with HPV vaccine uptake. Conclusions: Half of the school girls in the study area received the HPV vaccine. Interventions that enhance knowledge about the HPV vaccine and a positive attitude towards it can increase HPV vaccine uptake among schoolgirls.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.